1f0u: Difference between revisions

New page: left|200px<br /><applet load="1f0u" size="450" color="white" frame="true" align="right" spinBox="true" caption="1f0u, resolution 1.9Å" /> '''BOVINE TRYPSIN COMPLE...
 
No edit summary
Line 1: Line 1:
[[Image:1f0u.gif|left|200px]]<br /><applet load="1f0u" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1f0u.gif|left|200px]]<br /><applet load="1f0u" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1f0u, resolution 1.9&Aring;" />
caption="1f0u, resolution 1.9&Aring;" />
'''BOVINE TRYPSIN COMPLEXED WITH RPR128515'''<br />
'''BOVINE TRYPSIN COMPLEXED WITH RPR128515'''<br />


==Overview==
==Overview==
Involved in the coagulation cascade, factor Xa (FXa) is a serine protease, which has received great interest as a potential target for the, development of new antithrombotics. Although there is a great wealth of, structural data on thrombin complexes, few structures of ligand/FXa, complexes have been reported, presumably because of the difficulty in, growing crystals. Reproducible crystallization conditions for human, des-Gla1-45 coagulation FXa have been found. This has led to an, improvement in the diffraction quality of the crystals (about 2.1 A) when, compared to the previously reported forms (2.3-2.8 A) thus providing a, suitable platform for a structure-based drug design approach. A series of, crystal structures of noncovalent inhibitors complexed with FXa have been, determined, three of which are presented herein. These include compounds, containing the benzamidine moiety and surrogates of the basic group. The, benzamidine-containing compound binds in a canonical fashion typical of, synthetic serine protease inhibitors. On the contrary, molecules that, contain surrogates of the benzamidine group do not make direct, hydrogen-bonding interactions with the carboxylate of Asp189 at the bottom, of the S1 pocket. The structural data provide a likely explanation for the, specificity of these inhibitors and a great aid in the design of, bioavailable potent FXa inhibitors.
Involved in the coagulation cascade, factor Xa (FXa) is a serine protease which has received great interest as a potential target for the development of new antithrombotics. Although there is a great wealth of structural data on thrombin complexes, few structures of ligand/FXa complexes have been reported, presumably because of the difficulty in growing crystals. Reproducible crystallization conditions for human des-Gla1-45 coagulation FXa have been found. This has led to an improvement in the diffraction quality of the crystals (about 2.1 A) when compared to the previously reported forms (2.3-2.8 A) thus providing a suitable platform for a structure-based drug design approach. A series of crystal structures of noncovalent inhibitors complexed with FXa have been determined, three of which are presented herein. These include compounds containing the benzamidine moiety and surrogates of the basic group. The benzamidine-containing compound binds in a canonical fashion typical of synthetic serine protease inhibitors. On the contrary, molecules that contain surrogates of the benzamidine group do not make direct hydrogen-bonding interactions with the carboxylate of Asp189 at the bottom of the S1 pocket. The structural data provide a likely explanation for the specificity of these inhibitors and a great aid in the design of bioavailable potent FXa inhibitors.


==About this Structure==
==About this Structure==
1F0U is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with CA, SO4 and RPR as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Trypsin Trypsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.4 3.4.21.4] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1F0U OCA].  
1F0U is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with <scene name='pdbligand=CA:'>CA</scene>, <scene name='pdbligand=SO4:'>SO4</scene> and <scene name='pdbligand=RPR:'>RPR</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Trypsin Trypsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.4 3.4.21.4] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1F0U OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Trypsin]]
[[Category: Trypsin]]
[[Category: Becker, M.R.]]
[[Category: Becker, M R.]]
[[Category: Choi-Sledeski, Y.M.]]
[[Category: Choi-Sledeski, Y M.]]
[[Category: Ewing, W.R.]]
[[Category: Ewing, W R.]]
[[Category: Guilloteau, J.P.]]
[[Category: Guilloteau, J P.]]
[[Category: Klein, S.I.]]
[[Category: Klein, S I.]]
[[Category: Maignan, S.]]
[[Category: Maignan, S.]]
[[Category: Mikol, V.]]
[[Category: Mikol, V.]]
[[Category: Pauls, H.W.]]
[[Category: Pauls, H W.]]
[[Category: Pouzieux, S.]]
[[Category: Pouzieux, S.]]
[[Category: Spada, A.P.]]
[[Category: Spada, A P.]]
[[Category: CA]]
[[Category: CA]]
[[Category: RPR]]
[[Category: RPR]]
Line 29: Line 29:
[[Category: protein-inhibitor complex]]
[[Category: protein-inhibitor complex]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 14:30:35 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:33:34 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA